XML 91 R74.htm IDEA: XBRL DOCUMENT v3.8.0.1
Acquisition - Pro forma information (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Business Acquisition [Line Items]      
Revenues $ 277,743 $ 191,603 $ 196,129
Acquisition and integration costs 16,506 711 2,390
Amortization of inventory step-up to fair value 10,950 0 0
Triage Business      
Business Acquisition [Line Items]      
Pro forma total revenues 468,577 437,525  
Pro forma net income $ 41,296 $ 28,045  
Pro forma basic earnings per share $ 1,220 $ 860  
Pro forma diluted net earnings per share $ 1,180 $ 840  
Net loss included in the Consolidated Statement of Operations since acquisition $ (4,776)    
Acquisition and integration costs 11,700    
Amortization of inventory step-up to fair value 11,000    
Molecular      
Business Acquisition [Line Items]      
Revenues   $ 0 $ 0
Molecular | Triage Business      
Business Acquisition [Line Items]      
Revenues $ 47,030